Good luck! This village is full of billionaires

End of May.

United States, New Jersey.

Johnson & Johnson headquarters.

Frye took a document and knocked on the door of the CEO~O office.

He handed the document to CEO Alexander and reported: “BOSS, our branch in Xia Guo has privately contacted hundreds of people who have recovered from Alzheimer’s disease. These people who have recovered from Alzheimer’s disease have all participated in the report before

. Through clinical trials of Rainbow Manna Capsules.

By observing their physical conditions,

we found that the new drug does have a significant effect on Alzheimer’s disease.”

Alexander frowned after reading the documents in detail.

Since 1998, the world’s top pharmaceutical companies, such as Johnson & Johnson, Roche, Pfizer, Eli Lilly, Merck, Bayer, and AstraZeneca, have invested more than $600 billion in R&D funds in the field of Alzheimer’s disease.

But most of the funds were wasted.

Most of the new drugs developed fail in the first clinical phase.

Research and development of new drugs is extremely difficult!

The reason why these pharmaceutical companies are so persistent.

There are two main reasons.

First, there are 50 million Alzheimer’s disease (AD) patients in the world. Economically speaking, this field is a blue ocean.

Second, among the top ten leading causes of death in the country, the only disease that lacks effective treatment is Alzheimer’s disease.

Rainbow Pharmaceutical Co., Ltd. has now developed a new AD drug with remarkable efficacy.

This undoubtedly means.

In the future, the field of Alzheimer’s disease will be respected by Rainbow Pharmaceutical Co., Ltd.!

Major pharmaceutical companies around the world.

No one can compete with it!

Think of this.

Alexander knocked on the table and said in a solemn voice: “The market in the field of Alzheimer’s disease is more than one trillion US dollars. I am really unwilling to be taken away by Rainbow Pharmaceutical Co., Ltd. like this!” Fryhui reported:

” BOSS, there is also bad news from the laboratory.

The BACE inhibitor we developed failed in its first-phase clinical trial.

The company lost US$3.6 billion in the development of this drug.

If we include the bapineuzumab monoclonal antibody drug that failed in the 2012 clinical trial. , the company has lost more than 6.5 billion US dollars in the AD field in the past five years!”

Hearing this.

Alexander sighed.

US$6.5 billion in research and development expenses were wasted.

Johnson & Johnson is certainly the world’s number one pharmaceutical company.

But it cannot afford to suffer losses in drug research and development year after year.

If this continues.

His position as CEO may not be secure!

Johnson & Johnson is a leader in the pharmaceutical industry.

As the company’s CEO, he can be called the strongest “worker” in the medical industry, with an annual salary of US$29.58 million.

If you lose this position.

I will never find a position with a satisfactory salary in the future.

Alexander asked: “How is the drug research and development progress of companies such as Pfizer, Roche, and Eli Lilly?”

Fry quickly replied: “Purison has announced that it will no longer try to develop new AD drugs due to high research and development costs and poor efficacy. .

The gantenerumab monoclonal antibody drug previously developed by Roche failed in phase 1 clinical trials.

The α inhibitor previously developed by Eli Lilly failed in phase 1 clinical trials.

The project of the BACE inhibitor verubecestat drug previously developed by Merck has been stopped.

AstraZeneca previously developed The BACE inhibitor 1, anabecestat, failed in phase 1 clinical trials.

Biogen/Eisai previously developed aducanumab, a drug that failed in phase 1 clinical trials.”

The voice fell.

Alexander felt a little better.

Making innovative drugs can lead to a narrow escape from death.

Making innovative drugs for AD will lead to death.

Currently, none of the world’s top pharmaceutical companies can develop AD drugs.

At least he, the CEO, will not be dismissed.

As for the emergence of rainbow nectar capsules, it is a “crime other than war.”

Who would have thought.

Rainbow Manna Capsules do not follow the two research and development routes of BACE and A, but choose to start with intestinal bacteria.

Reshape the balance of intestinal bacteria.

It sounds extremely difficult.

But Rainbow Pharmaceutical Co., Ltd. actually did it!

Moreover, the total cost of corporate research and development seems to be only 300-400 million yuan in Xia national currency.

Not even 50 million US dollars…

At this time, Frye suggested: “BOSS, since we have developed a new AD drug, why not change the direction of research and development to a generic version of Rainbow Manna Capsules. What do you think?””

“generic drugs……”

Alexander laughed at himself: “As a leading company in the pharmaceutical field, we actually make generic drugs from Rainbow Pharmaceutical Co., Ltd. This is too cheap.” The

so-called generic drugs are copycat drugs.

However, it is very difficult for generic drugs to be marketed.

The U.S. FDA stipulates that generic drugs must be exactly the same as other patented drugs in terms of active ingredients, dosage, safety, efficiency, effects, side effects, and diseases targeted.

Johnson & Johnson is the world’s number one pharmaceutical company.

There is no reason to make a generic version of Rainbow Nectar!

“Have you forgotten the shelf life of your new drug? Alexander curled his lips and said: ”

Rainbow Manna Capsules have been submitted to the Xia State Drug Supervision and A

dministration Agency for new drug approval.”

Once a new drug is launched, Rainbow Manna Capsules can obtain a new drug certificate. (To read Baoshuang novels, go to Feilu Novel Network!)

What they obtained must be a Class I new drug certificate with a 12-year new drug protection period.

In other words, within the next 12 years, no pharmaceutical company will be able to produce generic versions of Rainbow Manna Capsules! ”

Hearing this, Fry came back to his senses.

New drug protection refers to the protection given by the state after the development of new drugs.

In the past, a pharmaceutical company spent huge sums of money to develop new drugs with remarkable effects.。[]

Other pharmaceutical companies jumped on the bandwagon, all developing similar drugs.

Over time, prices of similar products have been reduced, and profits have become thinner and thinner.

To this end, countries around the world have formulated corresponding new drug protection policies.

Internationally, the protection period for new drugs is as long as 20 years.

Suddenly, Frye said: “BOSS, if I remember correctly,

Xia Guo’s new drug protection period cannot be controlled in our country.

As long as Rainbow Manna Capsules have not obtained a new drug certificate from the FDA,

we can develop similar generic drugs!”

“That’s right! ”

Alexander said bluntly: “Even if we start generic research and development now, we still need clinical trials, clinical trials, and clinical trials.

At this time, Rainbow Pharmaceutical Co., Ltd. has obtained the FDA new drug certificate.

In terms of time, we simply don’t have time to make generic drugs!”

“Boom, boom, boom! ”

Secretary Lina hurriedly knocked on the door and came in.

She held a document and said to Alexander: “BOSS, it’s bad! Rainbow Pharmaceutical Co., Ltd. held another press conference to announce that hundreds of new drugs have passed clinical trials and are initiating new drug approval. ”

Alexander took the document and looked at it, and he was stunned.

There was dense new drug approval information on it.

The world’s first drug used to treat multiple types of rare hyperammonemia – iridoxine dispersible tablets, Xiang Xia Guo Pharmaceutical The regulatory agency initiated review and approval!

The world’s first drug for the treatment of type 1 hereditary tyrosinemia, rainbow nitisinone, was initiated for review and approval by the Xiaguo Food and Drug Administration! The world’s first drug for the treatment of relapsed

or refractory The drug for the treatment of multiple myeloma – Rainbow Ichiolense Injection, has been approved by the Xiaguo Drug Administration! The

world’s first targeted drug for the treatment of diffuse large B-cell lymphoma – Rainbow Injection Initiate review and approval from the Xia Guo Drug Administration for using vepotuzumab!

……

The world’s first targeted drug for second-line treatment of late-stage gastric cancer, Rainbow Ramosumab, has been approved by the Xia Guo Drug Administration!

The world’s first drug for the treatment of cholestasis in patients with Alageri syndrome – Rainbow IBAT inhibitor oral solution, has been submitted to the Xia Guo Drug Administration for approval!

The world’s first oral targeted drug for the treatment of EGFR localized or metastatic non-small cell lung cancer – Rainbow Moboxetinib Succinate Capsules, has been submitted to the Xia Guo Drug Administration for approval!

……

The world’s first drug to treat primary HLH difficult inflammatory syndrome, Rainbow Imalumab, has been approved by Xia Guo’s drug regulatory agency!

Rainbow belimumab, the world’s first biological agent with systemic coverage for lupus erythematosus and lupus nephritis indications, has been submitted to the Xia Guo Drug Administration for approval!

The world’s first factor Xa anticoagulant inhibitor for venous thrombosis in specific children and adolescents under the age of 18, Rainbow Varoxaban Tablets, has been submitted to the Xia Guo Drug Administration for approval!

……

Alexander, briefly browsed.

He was surprised to find that there were 500 new drugs on the file.

The most exaggerated thing is.

These new drugs are all unique and innovative drugs.

The assistant Frye on the side came over to take a look.

He asked inappropriately: “BOSS, what should we do next?”

“Let me think about it. Alexander

waved his hands feebly: “The advent of so many new drugs is undoubtedly a nightmare for all pharmaceutical companies around the world!” You guys should go out first, I want to have some quiet time alone。”

“Yes, BOSS! ”

Assistant Frye and secretary Lina nodded, turned and left.。

……

Inside the office.

Alexander let out a long sigh.

He knew it very well.

Rainbow Pharmaceutical Co., Ltd. has become the lifelong enemy of Johnson & Johnson!

Just rely on rainbow nectar capsules.

Rainbow Pharmaceutical Co., Ltd. will be able to rise rapidly and seize the global market.

There are now 500 new drugs approved for marketing.

This undoubtedly proves that Rainbow Pharmaceutical Co., Ltd. has strong research and development capabilities in various drug fields.

Facing such a strong rising star.

The future of Johnson & Johnson seems to be cast in a haze!

……

at the same time.

The world’s top pharmaceutical companies, including Pfizer, Novartis, Merck, Roche, Bayer, Eli Lilly, AbbVie, GlaxoSmithKline, and AstraZeneca, are all trembling.

The research and development capabilities of Rainbow Pharmaceutical Co., Ltd. are truly incredible!

For a time, the world’s top pharmaceutical companies fell into deep isolation…